[go: up one dir, main page]

NZ187926A - 19-nor-pregnahexaenes anti-mitotic pharmaceutical compositions - Google Patents

19-nor-pregnahexaenes anti-mitotic pharmaceutical compositions

Info

Publication number
NZ187926A
NZ187926A NZ187926A NZ18792678A NZ187926A NZ 187926 A NZ187926 A NZ 187926A NZ 187926 A NZ187926 A NZ 187926A NZ 18792678 A NZ18792678 A NZ 18792678A NZ 187926 A NZ187926 A NZ 187926A
Authority
NZ
New Zealand
Prior art keywords
pregnahexaenes
mitotic
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
NZ187926A
Inventor
R W Draper
C J Casmer
Original Assignee
Scherico Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherico Ltd filed Critical Scherico Ltd
Publication of NZ187926A publication Critical patent/NZ187926A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005Ketals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NZ187926A 1977-07-26 1978-07-21 19-nor-pregnahexaenes anti-mitotic pharmaceutical compositions NZ187926A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81918277A 1977-07-26 1977-07-26

Publications (1)

Publication Number Publication Date
NZ187926A true NZ187926A (en) 1980-10-08

Family

ID=25227423

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ187926A NZ187926A (en) 1977-07-26 1978-07-21 19-nor-pregnahexaenes anti-mitotic pharmaceutical compositions

Country Status (13)

Country Link
EP (1) EP0000609B1 (en)
JP (1) JPS5424864A (en)
AT (1) ATA532778A (en)
AU (1) AU518819B2 (en)
CA (1) CA1118410A (en)
DE (1) DE2861112D1 (en)
DK (1) DK326478A (en)
FI (1) FI782305A7 (en)
GR (1) GR73119B (en)
NO (1) NO782538L (en)
NZ (1) NZ187926A (en)
PT (1) PT68338A (en)
ZA (1) ZA784081B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4897290A (en) * 1986-09-26 1990-01-30 Konishiroku Photo Industry Co., Ltd. Method for manufacturing the substrate for liquid crystal display

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3410879A (en) * 1967-04-12 1968-11-12 American Home Prod Process for preparing gonahexaenes

Also Published As

Publication number Publication date
DK326478A (en) 1979-01-27
GR73119B (en) 1984-02-03
ATA532778A (en) 1982-12-15
JPS5424864A (en) 1979-02-24
PT68338A (en) 1978-08-01
DE2861112D1 (en) 1981-12-10
AU518819B2 (en) 1981-10-22
FI782305A7 (en) 1979-01-27
CA1118410A (en) 1982-02-16
NO782538L (en) 1979-01-29
ZA784081B (en) 1979-07-25
EP0000609B1 (en) 1981-09-23
AU3824878A (en) 1980-01-24
EP0000609A1 (en) 1979-02-07

Similar Documents

Publication Publication Date Title
ZA781398B (en) Pharmaceutical compositions
ZA785682B (en) Pharmaceutical compositions
GB2003028B (en) Pharmaceutical compositions
JPS53109934A (en) Pharmaceutical composition
JPS5484022A (en) Pharmaceutical composition
JPS5449333A (en) Pharmaceutical composition
JPS53133637A (en) Pharmaceutical composition
PH15193A (en) Pharmaceutical composition
GB2008403B (en) Pharmaceutical compositions
GB2021409B (en) Pharmaceutical composition
GB2002229B (en) Pharmaceutical composition
MW478A1 (en) Pharmaceutical compositions
ZA784470B (en) Pharmaceutical compositions including antithormbotic compositions
JPS5394038A (en) Pharmaceutical composition
IL54220A0 (en) Pharmaceutical compositions comprising trans-broparestrol
NZ186334A (en) Oxadiazolopyrimidines:pharmaceutical compositions
ZA78387B (en) Pharmaceutical compositions
GB2008408B (en) Pharmaceutical compositions
ZA7812B (en) Pharmaceutical compositions
JPS545045A (en) Pharmaceutical composition
GB1556851A (en) Pharmaceutical compositions
ZA782736B (en) Pharmaceutical compositions
JPS542338A (en) Pharmaceutical composition
JPS5480427A (en) Pharmaceutical composition having antiiviral property
GB2006010B (en) Pharmaceutical compositions